We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Aphton Corporation (NASDAQ:APHT) announced today that it has entered into a mutual decision and agreement to terminate the co-promotion and licensing agreement with sanofi pasteur related toAphton's lead immunotherapy compound, Insegia(TM) (G17DT immunogen).
Bayer raised its full-year earnings forecast after strong sales of plastics and prescription-free drugs helped it to easily beat analysts' forecasts for quarterly earnings, boosting its shares.
Swiss-based drugmaker Novartis said it had completed an agreement with Senju Pharmaceutical Co. over the development and commercialisation of a treatment for glaucoma, an eye disease.
Swiss drug firm Serono is putting out feelers for potential buyers, the Wall Street Journal reported Tuesday. The Geneva, Switzerland-based company is perusing possible suitors for a buyout or merger through investment bank Goldman Sachs Group, the report said.